Skip to Content

Crofelemer Pregnancy and Breastfeeding Warnings

Crofelemer is also known as: Fulyzaq, Mytesi

Crofelemer Pregnancy Warnings

Animal reproduction studies showed no impaired fertility, harm to the fetus, or adverse prenatal and postnatal effects in offspring at oral doses up to 177 times the recommended daily human dose. Abortions and resorptions of fetuses occurred in pregnant animals at oral doses of about 96 times the recommended daily human dose, but these effects could be related to maternal toxicity. There are no controlled data in human pregnancy. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Use only if clearly needed. FDA pregnancy category: C

See references

Crofelemer Breastfeeding Warnings

A decision should be made to discontinue breast-feeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Unknown The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Fulyzaq (crofelemer)." Salix Pharmaceuticals, Raleigh, NC.

References for breastfeeding information

  1. "Product Information. Fulyzaq (crofelemer)." Salix Pharmaceuticals, Raleigh, NC.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.